Target intelligence / Profile preview

Nuclear protein localization protein 4 (NPL4)

Target
NPL4
Molecular classification
Protein cofactor/adaptor, Ubiquitin-binding protein, Component of the p97/Cdc48-Ufd1-Npl4 ATPase complex, Ubiquitin ligase complex component (in yeast), Zinc finger protein (has C-terminal zinc finger domain in mammals)
01

Overview

Nuclear protein localization protein 4 (NPL4, also known as NPLOC4 in humans) is a critical protein cofactor that functions in concert with Ufd1 and p97 (VCP in mammals, Cdc48 in yeast) to recognize and extract polyubiquitylated substrates from membranes, especially in the ER-associated degradation (ERAD) pathway[1][3][4][6][7]. The NPL4-Ufd1-p97 complex is essential for retrotranslocation of misfolded or regulatory proteins from the endoplasmic reticulum into the cytosol for proteasomal degradation, and for the activation of key transcription factors involved in membrane lipid biosynthesis in yeast[2]. NPL4 contains multiple domains including a zinc finger and MPN domain for ubiquitin binding, and is implicated in regulating mitotic spindle disassembly and nuclear envelope reformation in eukaryotic cells[1][3][6]. Dysfunction or mutation of NPL4 can have severe consequences for cell viability and is implicated in several cellular quality control pathways.

Other names
Nuclear protein localization protein 4NPL4NPLOC4 (especially in mammalian contexts)Hrd4 (in yeast, synonymous with ERAD gene HRD4)Npl4p (yeast protein notation)
02

Mechanism of action

Drugs or molecules targeting this complex generally act by inhibiting ATPase-mediated retrotranslocation and proteasomal degradation, affecting cellular protein turnover Experimental disruption of NPL4 function can impair ERAD and induce cell death through proteostasis imbalance

03

Biological functions

Ubiquitin-dependent proteasomal degradation pathway cofactorRecognition and processing of polyubiquitylated proteinsER-associated protein retrotranslocationRegulation of mitotic spindle disassembly and nuclear envelope reformation at end of mitosisActivation of transcription factors by proteolytic processing (Mga2p, Spt23p in yeast)Participates in membrane trafficking
04

Disease associations

Cancer (aberrations in proteasomal or ERAD functions are implicated in tumorigenesis)Neurodegenerative diseases (as ERAD and proteostasis defects have disease relevance)Other (general protein quality control pathology possible; direct links to specific human diseases not as strongly established in current literature)
05

Safety considerations

Targeting NPL4 or the Cdc48/p97-Ufd1-Npl4 complex can cause widespread disruption in cellular protein homeostasis and may have profound effects on essential cell functions, leading to cytotoxicity or off-target tissue effects.Therapeutic targeting would need careful modulation to avoid fatal loss of proteasomal quality control.
06

Interacting drugs

No specific approved drugs directly targeting NPL4 are listed in current major databases or literature. However, small molecules modulating the p97 (VCP)-Ufd1-Npl4 pathway are under investigation in preclinical research.
07

Biomarkers

There are currently no validated biomarkers based specifically on NPL4 for clinical patient selection or efficacy monitoring.NPL4 pathway activity may be explored as surrogate markers of ERAD capacity or proteasomal function in experimental settings.

Beyond the preview

Go deeper on Nuclear protein localization protein 4 (NPL4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear protein localization protein 4 (NPL4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call